Michael Ciarametaro
Michael Ciarametaro serves as the National Pharmaceutical Council's vice president of research. In this position, Mr. Ciarametaro plays a key role in developing and delivering NPC’s portfolio of health policy and health outcomes projects. Mr Ciarametaro has 13 years of health care industry experience with both pharmaceutical manufacturers and payers. Most recently, he was a senior research manager at Evidera, where he designed and led a wide variety of both qualitative and quantitative studies across multiple health care industries and stakeholders. Mr. Ciarametaro’s work analyzed reimbursement and treatment patterns for drugs, biologicals and devices. Prior to Evidera, he served as …
Michael Ciarametaro serves as the National Pharmaceutical Council's vice president of research. In this position, Mr. Ciarametaro plays a key role in developing and delivering NPC’s portfolio of health policy and health outcomes projects.
Mr Ciarametaro has 13 years of health care industry experience with both pharmaceutical manufacturers and payers. Most recently, he was a senior research manager at Evidera, where he designed and led a wide variety of both qualitative and quantitative studies across multiple health care industries and stakeholders. Mr. Ciarametaro’s work analyzed reimbursement and treatment patterns for drugs, biologicals and devices. Prior to Evidera, he served as a financial analysis manager at WellPoint NextRx and as lead staff at Noblis, a nonprofit science, technology and strategy organization.
Mr Ciarametaro holds a Bachelor of Science from the University of Virginia and received his MBA from George Mason University.
See more
Mr Ciarametaro has 13 years of health care industry experience with both pharmaceutical manufacturers and payers. Most recently, he was a senior research manager at Evidera, where he designed and led a wide variety of both qualitative and quantitative studies across multiple health care industries and stakeholders. Mr. Ciarametaro’s work analyzed reimbursement and treatment patterns for drugs, biologicals and devices. Prior to Evidera, he served as a financial analysis manager at WellPoint NextRx and as lead staff at Noblis, a nonprofit science, technology and strategy organization.
Mr Ciarametaro holds a Bachelor of Science from the University of Virginia and received his MBA from George Mason University.
Articles: Michael Ciarametaro
Supporting Value-Based Purchasing in the US Through Changes in Medicaid Best Price
USA / Michael Ciarametaro, VP for Research at the US National Pharmaceutical Council (NPC), outlines issues surrounding the outdated Medicaid Best Price (MBP) and why there is a dire need for payment innovations to provide a way for US payers and manufacturers to share financial risk and ultimately ensure that patients can access treatments. Our national…
Latest Report
